Atrial Fibrillation and Anticoagulation
Michael A. Chen, MD, PhD
Department of Medicine (Cardiology)
School of Medicine
University of Washington
By the end of this lecture, you should be able to:
Describe methods of stroke risk assessment in patients with atrial fibrillation.
Describe methods of assessing bleeding risk in patients on anticoagulant medications.
Discuss the benefits and drawbacks of alternative strategies (e.g., anti-platelet medications, newer anticoagulants) for stroke risk reduction in atrial fibrillation.
[From the Winter 2013 Geriatric Healthcare Lecture Series]